Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Unity Biotechnology, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 98 | 2 | 84 | −12 |
| Shares | 18.1M | 1.61M | 13.8M | −2.72M (−16.5%) |
| Value | $84.0M | $7.49M | $42.1M | −$34.4M (−45.0%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Unity Biotechnology, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Franklin Resources Inc | 92,900 | $279.0K | 0.00% |
| Algert Global LLC | 32,412 | $97.0K | 0.01% |
| Moloney Securities Asset Management, LLC | 21,000 | $63.0K | 0.01% |
| ProShare Advisors LLC | 11,772 | $35.0K | 0.00% |
| Quantbot Technologies LP | 1,500 | $4.00K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 200 | $0 | 0.00% |
Sold out (18)
Institutions that held Unity Biotechnology, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Tibra Equities Europe Ltd | 80,700 | $374.0K |
| Qube Research & Technologies Ltd | 45,133 | $209.0K |
| Jump Financial, LLC | 33,700 | $156.0K |
| Parametric Portfolio Associates LLC | 31,399 | $146.0K |
| Jane Street Group, LLC | 21,655 | $100.0K |
| AXA S.A. | 21,000 | $97.0K |
| LMR Partners LLP | 19,158 | $89.0K |
| Nations Financial Group Inc, | 18,917 | $88.0K |
| Walleye Trading LLC | 16,378 | $76.0K |
| Dynamic Technology Lab Private Ltd | 15,813 | $73.0K |
| Level Four Advisory Services, LLC | 11,710 | $54.0K |
| Raymond James Financial Services Advisors, Inc. | 10,105 | $47.0K |
| Boothbay Fund Management, LLC | 10,002 | $46.0K |
| Ford Financial Group, LLC | 500 | $2.00K |
| New York State Common Retirement Fund | 284 | $1.00K |
| Allworth Financial LP | 200 | $1.00K |
| Federation des caisses Desjardins du Quebec | 200 | $928 |
| Belvedere Trading LLC | 86 | $0 |
Not filed for Q3 2021 yet (2)
Institutions that held Unity Biotechnology, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Mayo Clinic | 1,571,981 | $7.29M |
| 20/20 Capital Management, Inc. | 42,840 | $199.0K |